#USA #San Diego #C150 #Seraphina Therapeutics #fatty15

Seraphina Therapeutics Achieves Remarkable Growth

In a notable achievement for the health and wellness sector, Seraphina Therapeutics has been recognized as the fastest-growing health and wellness company in the Pacific by Inc. magazine. This recognition is largely attributed to the success of their flagship product, the fatty15 supplement, which has received widespread acclaim and solidified a loyal customer base. The announcement was made on April 1, 2026, and highlights the innovative strides being made by the company.

Standing Out in the Competitive Market

Seraphina Therapeutics has climbed to No. 11 on the esteemed Inc. Regionals Pacific list, which ranks privately held companies based on revenue growth across several states, including California and Washington. This accolade is further extended from the national Inc. 5000 list, showcasing the company's undeniable impact in a challenging economic climate.

The Pacific region's economic landscape has been notably challenging, but the founders and employees of Seraphina Therapeutics have shown exceptional determination. Dr. Eric Venn-Watson, Co-Founder and Co-CEO, expresses pride in their accomplishment, stating, “We are honored to be recognized as the fastest-growing health and wellness company in the Pacific, furthering our mission to deliver health solutions that significantly enhance lives.” This passion translates deeply into their product development and company culture.

The Focus on Health and Innovation

The formula behind the success of fatty15 lies in its scientific foundation. Developed with input from both physicians and veterinary scientists, the supplement contains C150 (pentadecanoic acid), a unique nutrient that has been shown to promote healthy cell functions and combat age-related issues. Over 100 peer-reviewed studies validate its role as a crucial component in fostering healthy aging in individuals of all ages.

Dr. Stephanie Venn-Watson, the co-creator of the fatty15 supplement, made a groundbreaking discovery during her time as a veterinary epidemiologist for the Navy. She observed that older Navy dolphins exhibited various health challenges, which led her team to identify C150 as a key factor in their overall health. This research laid the groundwork for the development of fatty15 and guides the mission of Seraphina Therapeutics today.

Since its launch in January 2021, the fatty15 supplement has captured public interest and demonstrated a notable 95% monthly retention rate — a testament to its efficacy and customer satisfaction. The product's impact on global health, alongside its award-winning accolades, has made Seraphina a standout entity in the health and wellness industry.

Resilience Amid Economic Challenges

The current economic landscape poses various challenges; however, the results of the Inc. Regionals Pacific list commend the resilience of companies like Seraphina. The 134 companies featured in this year's report averaged a 94% growth rate and contributed over $2.5 billion to the region's economy while creating 7,503 jobs between 2022 and 2024. As noted by Bonny Ghosh, the editorial director at Inc., companies were able to innovate and thrive despite significant economic hurdles.

Through ongoing commitment and excellence, Seraphina Therapeutics continues to make strides in advancing health and wellness. The firm’s recognition as the fastest-growing health and wellness company in the Pacific region for 2026 stands as a powerful symbol of hope and progress. By harnessing science and advocating for healthy aging, Seraphina is not just shaping the industry; it is also leaving a lasting impact on the global health landscape.

To learn more about their products and mission, visit fatty15.com or DiscoverC15.com. Their commitment to healthy aging solutions offers promising possibilities for consumers seeking alternatives in health care.